This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Aetiology

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Myasthenia gravis an autoimmune disease in which antibodies result in a loss of muscle acetylcholine (ACh) receptors (AChRs). In 85% of cases the antibodies bind to the AChRs themselves ('seropositive') and in the remaining cases (misleadingly described as 'seronegative') the antibodies bind to a different muscle membrane target (1).

Neonatal myasthenia may result from the antibody being passively transferred to a fetus in utero. This condition will be transient.

There are associations between myasthenia gravis and thymic hyperplasia - 75% of cases - and thymoma -15%. Antibodies to striated muscle are usually present in the latter group.

The condition may be exacerbated by drugs, e.g. penicillamine, lithium, aminoglycosides, and phenytoin.

Reference:

  • Prescribers' Journal 2000; 40 (2): 93-96.
  • Jeffrey M. Statland, Emma Ciafaloni. Myasthenia gravis: Five new things Neurol Clin Pract. 2013 April; 3(2): 126-133.

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page